Company intelligence / Profile preview

DIAGAST

Loos, Hauts-de-France, Francediagast.com ↗

Ownership: Private
Employees: ~201
Development stage: Commercial

Overview

DIAGAST offers a comprehensive portfolio of commercialized products for blood group determination and immunohematology diagnostics, including monoclonal antibodies, reagents, point-of-care tests, and automated systems. The company has achieved IVDR certification for class D products and supplies nearly 1,000 clients in over 100 countries with annual sales of approximately €50 million.

Therapeutic areas: Hematology
Modalities: Monoclonal antibodyDiagnostic deviceReagent (for blood typing)Automated system (for immunohematology)
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on DIAGAST.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DIAGAST.

Explore the full profile